Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group

H Partsch, N Stout, I Forner-Cordero, M Flour, C Moffat, A Szuba, D Milic, G Szolnoky, H Brorson, M Abel, J Schuren, F Schingale, S Vignes, Neil Piller, W Doller

    Research output: Contribution to journalReview article

    25 Citations (Scopus)

    Abstract

    Aim. A mainstay of lymphedema management involves the use of compression therapy. Compression therapy application is variable at different levels of disease severity. Evidence is scant to direct clinicians in best practice regarding compression therapy use. Further, compression clinical trials are fragmented and poorly extrapolable to the greater population. An ideal construct for conducting clinical trials in regards to compression therapy will promote parallel global initiatives based on a standard research agenda. The purpose of this article is to review current evidence in practice regarding compression therapy for BCRL management and based on this evidence, offer an expert consensus recommendation for a research agenda and prescriptive trials. Recommendations herein focus solely on compression interventions. Methods. This document represents the proceedings of a session organized by the International Compression Club (ICC) in June 2009 in Ponzano (Veneto, Italy). The purpose of the meeting was to enable a group of experts to discuss the existing evidence for compression treatment in breast cancer related lymphedema (BCRL) concentrating on areas where randomized controlled trials (RCTs) are lacking. Results. The current body of research suggests efficacy of compression interventions in the treatment and management of lymphedema. However, studies to date have failed to adequately address various forms of compression therapy and their optimal application in BCRL. We offer recommendations for standardized compression research trials for prophylaxis of arm lymphedema and for the management of chronic BCRL. Suggestions are also made regarding; inclusion and exclusion criteria, measurement methodology and additional variables of interest for researchers to capture. Conclusion. This document should inform future research trials in compression therapy and serve as a guide to clinical researchers, industry researchers and lymphologists regarding the strengths, weaknesses and shortcomings of the current literature. By providing this construct for research trials, the authors aim to support evidence-based therapy interventions, promote a cohesive, standardized and informative body of literature to enhance clinical outcomes, improve the quality of future research trials, inform industry innovation and guide policy related to BCRL.

    Original languageEnglish
    Pages (from-to)442-453
    Number of pages12
    JournalInternational Angiology
    Volume29
    Issue number5
    Publication statusPublished - Oct 2010

    Keywords

    • Bandages
    • Breast neoplasms
    • Lymphedema

    Fingerprint Dive into the research topics of 'Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group'. Together they form a unique fingerprint.

  • Cite this

    Partsch, H., Stout, N., Forner-Cordero, I., Flour, M., Moffat, C., Szuba, A., Milic, D., Szolnoky, G., Brorson, H., Abel, M., Schuren, J., Schingale, F., Vignes, S., Piller, N., & Doller, W. (2010). Clinical trials needed to evaluate compression therapy in breast cancer related lymphedema (BCRL). Proposals from an expert group. International Angiology, 29(5), 442-453.